Coliseum Capital Management, LLC

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$1.21B
Notable people
Adam Gray, Christopher S. Shackelton
Signature - Title
Adam Cina - Attorney-in-fact for Coliseum Capital Management, LLC
Location
Rowayton, CT
Summary
This page shows a list of all the recent 13F filings made by Coliseum Capital Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Coliseum Capital Management, LLC reported 14 stock holdings with total value $1.21B as of Q4 2024. Top holdings included GIL, UTI, SONO, GMS, and HRI.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 14 $1.21B +$303M -$195M +$108M GIL, UTI, SONO, GMS, HRI 13F-HR 2/14/2025, 04:16 PM
Q3 2024 14 $1.03B +$183M -$335M -$152M GIL, UTI, SONO, GMS, HRI 13F-HR 11/14/2024, 04:20 PM
Q2 2024 14 $1.12B +$128M -$31.8K +$128M GIL, UTI, RCM, MODV, GMS 13F-HR 8/14/2024, 04:15 PM
Q1 2024 11 $1.08B +$70.2M -$342M -$272M GIL, UTI, RCM, PRPL, SONO 13F-HR 5/15/2024, 04:05 PM
Q4 2023 11 $1.25B +$233M -$106M +$127M GIL, GMS, UTI, MODV, SONO 13F-HR 2/14/2024, 04:26 PM
Q3 2023 14 $959M +$127M -$82.2M +$44.7M GIL, GMS, MODV, SONO, PRPL 13F-HR 11/14/2023, 04:22 PM
Q2 2023 13 $1.11B +$126M -$338M -$212M GIL, GMS, PRPL, SONO, MODV 13F-HR 8/14/2023, 05:51 PM
Q1 2023 12 $1.32B +$171M -$28.3M +$143M GMS, GIL, SONO, PRPL, MODV 13F-HR 5/15/2023, 04:58 PM
Q4 2022 13 $1.34B +$128M -$154M -$26.1M GMS, BLDR, PRPL, GIL, MODV 13F-HR 2/14/2023, 03:15 PM
Q3 2022 13 $1.23B +$127M -$64.9M +$62.4M BLDR, GMS, PRPL, MODV, SONO 13F-HR 11/14/2022, 03:57 PM
Q2 2022 14 $1.13B +$156M -$2.8M +$153M BLDR, GMS, PRPL, MODV, SONO 13F-HR 8/15/2022, 05:39 PM
Q1 2022 13 $1.33B +$337M +$337M BLDR, GMS, PRPL, MODV, SONO 13F-HR 5/16/2022, 04:13 PM
Q4 2021 11 $1.31B +$269M -$360M -$90.9M BLDR, GMS, PRPL, MODV, BLBD 13F-HR 2/14/2022, 03:15 PM
Q3 2021 8 $1.13B +$16.9M -$47.2M -$30.3M BLDR, MODV, GMS, PRPL, GORV 13F-HR 11/16/2021, 09:52 AM
Q2 2021 7 $1.13B +$34.9M -$200M -$165M BLDR, MODV, GMS, PRPL, GORV 13F-HR 8/16/2021, 04:41 PM
Q1 2021 7 $1.34B +$711M -$631M +$80.1M PRPL, BLDR, MODV, GMS, GORV 13F-HR 5/17/2021, 04:15 PM
Q4 2020 10 $1.22B +$176M -$67.3M +$109M PRPL, BMCH, PRSC, GMS, FBM 13F-HR 2/16/2021, 03:30 PM
Q3 2020 12 $935M +$65.9M -$16.6M +$49.3M BMCH, PRPL, PRSC, GIL, GMS 13F-HR 11/16/2020, 03:15 PM
Q2 2020 13 $686M +$208M -$46.9M +$161M PRPL, BMCH, PRSC, GIL, GMS 13F-HR 8/14/2020, 04:12 PM
Q1 2020 18 $369M +$127M -$2.66M +$124M BMCH, PRSC, PRPL, LGC, CNR 13F-HR 5/15/2020, 04:00 PM
Q4 2019 11 $376M +$76.7M -$23.1M +$53.6M BMCH, PRPL, PRSC, CNR, LGC 13F-HR 2/14/2020, 03:35 PM
Q3 2019 15 $362M +$64.4M -$39.2M +$25.2M BMCH, PRSC, PRPL, BXC, CNR Restatement 2/14/2020, 03:10 PM
Q2 2019 13 $309M +$30.7M +$30.7M PRSC, BMCH, PRPL, LGCU, RLH 13F-HR 8/14/2019, 04:28 PM
Q1 2019 13 $277M +$15.3M -$2.45M +$12.8M PRSC, BMCH, LGCU, RLH, PRPL 13F-HR 5/15/2019, 04:30 PM
Q4 2018 13 $268M +$57.6M +$57.6M PRSC, PRPL, BMCH, LGCU, RLH 13F-HR 2/14/2019, 03:16 PM
Q3 2018 9 $246M +$18.7M +$18.7M PRSC, RLH, PRPL, LGCU, BKD 13F-HR 11/13/2018, 04:48 PM
Q2 2018 8 $254M +$45.4M -$33.7M +$11.7M PRSC, PRPL, RLH, LGCU, BKD 13F-HR 8/14/2018, 04:53 PM
Q1 2018 10 $249M +$73.7M -$519K +$73.1M PRSC, PRPL, LGCU, LHCG, UTI 13F-HR 5/15/2018, 05:03 PM
Q4 2017 8 $157M +$38.5M -$21.5M +$17M PRSC, LGCU, UTI, ADES, LHCG 13F-HR 2/14/2018, 04:18 PM
Q3 2017 5 $135M -$10.3M -$10.3M PRSC, UTI, ADES, BIOSXXXX, DXLG 13F-HR 11/14/2017, 02:47 PM
Q2 2017 8 $164M -$64.5M -$64.5M PRSC, BIOSXXXX, UTI, BLBD, LHCG 13F-HR 8/14/2017, 03:22 PM
Q1 2017 10 $222M +$10.3M -$28.4M -$18.1M PRSC, LHCG, ASNA, ADES, BLBD 13F-HR 5/15/2017, 04:56 PM
Q4 2016 7 $222M -$6.4M -$6.4M PRSC, BLBD, LHCG, ASNA, ADES 13F-HR 2/14/2017, 04:34 PM
Q3 2016 10 $285M +$30.4M +$30.4M PRSC, BLBD, LHCG, ASNA, ACW 13F-HR 11/14/2016, 04:30 PM
Q2 2016 9 $240M +$22.5M -$6.49M +$16M PRSC, LHCG, ASNA, BLBD, BIOSXXXX 13F-HR 8/15/2016, 05:05 PM
Q1 2016 11 $258M +$26M -$16.4M +$9.58M PRSC, ASNA, LHCG, BLBD, UTI 13F-HR 5/16/2016, 04:17 PM
Q4 2015 11 $246M +$25.8M -$17.1M +$8.61M PRSC, LHCG, BLBD, ASNA, UTI 13F-HR 2/16/2016, 04:09 PM
Q3 2015 8 $248M +$6M -$25.9M -$19.9M PRSC, LHCG, ASNA, BLBD, ACW 13F-HR 11/16/2015, 03:06 PM
Q2 2015 8 $295M +$9.1M -$53.9M -$44.8M PRSC, LHCG, ASNA, BLBD, ACW 13F-HR 8/14/2015, 04:28 PM
Q1 2015 8 $332M +$35.6M -$2.8M +$32.8M PRSC, LHCG, CROX, ACW, ASNA 13F-HR 5/15/2015, 01:24 PM
Q4 2014 9 $311M +$36.2M -$918K +$35.3M PRSC, LHCG, ADES, CROX, ACW 13F-HR 2/17/2015, 07:40 PM
Q3 2014 8 $280M +$16.9M -$19.2M -$2.29M PRSC, LHCG, CROX, ADES, ACW 13F-HR 11/14/2014, 10:42 AM
Q2 2014 10 $298M +$26.6M -$5.44M +$21.1M PRSC, LHCG, ACW, CROX, ADES 13F-HR 8/14/2014, 04:39 PM
Q1 2014 12 $259M +$48.9M -$16.9M +$32M PRSC, LHCG, ACW, CROX, MED 13F-HR 5/15/2014, 04:20 PM
Q4 2013 11 $236M LHCG, PRSC, CROX, ACW, JMBA 13F-HR 2/14/2014, 03:00 PM